EBS Technologies | Updates

By Ulf Pommerening

EBS Secures Additional Financing of 1.1 Million Euros




Dear Companists,

I am very pleased to announce that EBS Technologies recently received €1.1m in another financing round. We had already announced the negotiations on this financing round in our last quarterly update, and the financing round is now complete.

In addition to our existing investors Earlybird Venture Capital and High-Tech Gründerfonds, three private investors recently invested in EBS Technologies. These private investors include Rainer Christine, who – like our 689 Companists who invested €258,825 on Companisto in early 2015 – believes that our EBS therapy method has great potential within the rapidly growing neural stimulation market. The Companisto campaign has not only helped EBS in a financial sense; the considerable feedback from the market caused by the Companists has also helped EBS make considerable progress.

This latest financing round is another important milestone for us and for our Companists. We plan to use the fresh capital to further improve our market position in Germany and to boost international expansion. The financing round is still open to new investors, and we plan to use additional capital for accessing the interesting U.S. market, where we have already applied for patents on our technology.

We will keep you posted about the latest developments!

Best regards,

Ulf Pommerening, managing director of EBS Technologies


Only registered Companists can comment. Please log in to leave a comment.


Investments in startups and growth companies offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, investments in startups or growth companies are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by diversifying the amount they invest in startups and growth companies and not investing the entire amount in one startup or growth company. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the investors on Companisto are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the investors (Companists) – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, investments in startups and growth companies are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

€ 258,825




3.67 %

Share Offered

Please note
The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.
Contact Us
If you have any questions about investing on Companisto, please contact our service team:

Toll-free phone number for investors calling from Germany:
0800 - 100 267 0

Companisto investors hotline:
+49(0)30 - 346 491 493

We are available Monday through Friday between 9 a.m. – 6 p.m.

For companies
Apply for financing Investment Model FAQ for Companies
Investor Support